Gov. Mike Kehoe (R) signed two bills that include a provision to raise the 12-month purchase limit for ephedrine, phenylpropanolamine and pseudoephedrine from 43.2 grams to 61.2 grams, while keeping existing daily and monthly limits. The bill also requires manufacturers to fund a real-time tracking system for the sale of the products beginning on October 1. For more information, see HB 2372 & SB 878. 

Also in Missouri, on August 1, pharmacists can begin renewing their license. To renew, pharmacists must complete 30 hours of approved continuing education (CE) prior to renewing.  

For more information, contact NACDS’ Mary Staples at 817-442-1155.

MO HealthNet is required to complete an annual review of all drug coverage criteria per 13 CSR 70-20.200 Drug Prior Authorization Process – Pharmacy Clinical Edits and Preferred Drug Lists.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Gov. Mike Kehoe (R) signed SB 878, legislation sponsored by former Senator Travis Fitzwater (R) that strengthens pharmacy practice by expanding patient access to care. The bill allows pharmacists to order and administer FDA-approved or authorized vaccines and prescribe certain medical devices.

Also in Missouri, Gov. Kehoe (R) approved HB 2372, legislation allowing pharmacists to order and administer certain FDA-approved or authorized vaccines. The bill also permits pharmacists to independently prescribe certain medical devices.

Finally in Missouri, Gov. Kehoe (R) SB 1233, legislation allowing ordering and administering of certain vaccines approved or authorized by the FDA.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Navigating the MO HealthNet (Missouri Medicaid) enrollment process can be complex. To get started, visit the provider enrollment application. Before reaching out for support, check the Provider Enrollment Guide on the Missouri Medicaid Audit and Compliance (MMAC) Provider Enrollment webpage. The fastest way to find answers in the Guide is to check the Index or select your specific Provider Type. 

Also in Missouri, the Board of Pharmacy posted the agenda and meeting materials for a virtual open meeting on July 15. 

Finally in Missouri, the Board will be hosting a two-hour webinar for Missouri pharmacists-in-charge (PIC) on July 23, covering the PIC's responsibilities, inspector tips for PICs, regulatory requirements/changes, recent compliance and inspection trends, expanded scope of practice and patient safety best practices.  

For more information, contact NACDS’ Mary Staples at 817-442-1155.

The Department of Health and Senior Services (DHSS) renewed the naloxone standing order with a June 2, 2027, expiration date.  

Also in Missouri, effective June 1, MOHealthNet no longer offers manual overrides for pharmacy claims rejected due to missing or incorrectly formatted ICD-10 diagnosis codes under the Diagnosis Code Required Policy Edit, as found in the Pharmacy Clinical Edits and Preferred Drug Lists. Claims for agents included in the Diagnosis Code Required Policy Edit must include a valid, billable ICD-10 code to be processed successfully. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

NACDS sent Gov. Mike Kehoe (R) a letter urging him to sign SB 878, landmark legislation expanding pharmacists' ability to serve patients. The bill modernizes pharmacy law and includes several important provisions that strengthen the profession and improve patient access to care, including: 

• Expanding pharmacists' authority to provide patient care services under statewide protocols and collaborative practice arrangements. 

• Updating vaccine authority to allow pharmacists to administer additional FDA-approved vaccines. 

• Authorizing pharmacists to prescribe certain medical devices. 

• Removing unnecessary barriers to medication therapeutic plan authority. 

• Protecting 340B covered entities from discriminatory reimbursement practices. 

• Modernizing pharmacy statutes to reflect current practice and healthcare delivery. 

Also in Missouri, effective June 1, MO HealthNet (Medicaid) will no longer offer manual overrides for pharmacy claims rejected due to missing or incorrectly formatted ICD-10 diagnosis as found in the Pharmacy Clinical Edits and Preferred Drug Lists. This update means that claims for agents included in the Diagnosis Code Required Policy Edit must include a valid, billable ICD-10 code to be processed successfully. 

Finally in Missouri, MO HealthNet is required to complete an annual review of all drug coverage criteria per 13 CSR 70-20.200 Drug Prior Authorization Process – Pharmacy Clinical Edits and Preferred Drug Lists. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

SB 878, legislation expanding pharmacists’ scope authority for CLIA-waived tests, ordering and administering vaccines and allowing for prescribing certain types of medical equipment, passed both houses and was sent to Gov. Mike Kehoe (R).

Finally in Missouri, the General Assembly is scheduled to adjourn on May 15.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

SB 878, was amended and passed the Senate on March 23. The bill expands pharmacists’ scope authority for CLIA-waived tests and allows prescribing certain types of medical equipment. It also enhances the Board of Pharmacy’s authority to allow pharmacies to dispense medications during a declared emergency. In addition, it would allow the over-the-counter sale of ivermectin and hydroxychloroquine, with a warning label, once the FDA authorizes them for over-the-counter dispensing. The bill was sent to the House of Representatives for further action.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

SB 878 was amended and passed the Senate on March 23. The bill expands pharmacist scope authority for CLIA-waived tests and allows prescribing of certain types of medical equipment. It also enhances the Board of Pharmacy’s authority to allow pharmacies to dispense medications during a declared emergency. In addition, it would allow the over-the-counter sale of ivermectin and hydroxychloroquine, with a warning label, once the FDA authorizes them for over-the-counter dispensing. The bill was sent the House of Representatives for further action.

For more information, contact NACDS’ Mary Staples at 817-442-1155.